DarioHealth
DRIO
35 hedge funds and large institutions have $15.3M invested in DarioHealth in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 9 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
0.24% less ownership
Funds ownership: 1.85% → 1.61% (-0.24%)
15% less funds holding
Funds holding: 41 → 35 (-6)
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
54% less capital invested
Capital invested by funds: $33M → $15.3M (-$17.7M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$210K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$109K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$58.7K |
| 4 |
AWAM
Appian Way Asset Management
New York
|
+$57.8K |
| 5 |
Goldman Sachs
New York
|
+$55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$3.97M |
| 2 |
SC
Shay Capital
New York
|
-$492K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$312K |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$285K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$138K |
DRIO Hedge Fund Activity: Q4 2023 in Review
35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2023, worth a combined $15.3M — down 54% from $33M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of DRIO and 3 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 13 added.
The largest buyer was Morgan Stanley, adding an estimated $210K. The largest seller was Walleye Capital, exiting entirely with an estimated $3.97M sold.
- 35 institutional investors held DarioHealth (DRIO) as of Q4 2023, down from 41 in Q3 2023.
- Funds reported $15.3M of DarioHealth stock for Q4 2023, down 54% quarter-over-quarter.
- 3 funds opened new DarioHealth positions in Q4 2023 and 9 closed out, a net change of -6 holders.
- The largest DarioHealth buyer in Q4 2023 was Morgan Stanley, an estimated $210K added.
- The largest DarioHealth seller in Q4 2023 was Walleye Capital, an estimated $3.97M sold.
Based on aggregated 13F filings for Q4 2023.